Fedenia Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History

Fedenia Advisers’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.8K	Buy	+75	New	+$51.1K	0.01%	222

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Fedenia Advisers's REGN Position: Q2 2026 in Review

Fedenia Advisers opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 75 shares worth $46.8K. The stake represents 0.01% of the portfolio and ranks #222 among its holdings.

334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Fedenia Advisers held 75 shares of Regeneron Pharmaceuticals worth $46.8K as of Q2 2026.
Regeneron Pharmaceuticals was a new Fedenia Advisers position in Q2 2026.
Regeneron Pharmaceuticals made up 0.01% of Fedenia Advisers's portfolio in Q2 2026, its #222 holding.
334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.